Sr. Medical Director, Clinical Development

Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description:

The Senior Medical Director, Clinical Development (SMDCD) will be assisting in the implementation of the Replimune drug development strategy and will be taking a leadership and contributor role in enabling all aspects of individual drug programs. The SMDCD will lead or support conduct of clinical studies and will work closely with colleagues in clinical development, program leadership, biometrics, clinical operations, safety/pharmacovigilance, regulatory, molecular diagnostics, and translational research. The SMDCD will provide clinical input on clinical protocol development, regulatory interactions, patient enrollment to clinical studies, safety monitoring and review, biomarker development, implementation and analysis of data, manuscript writing and submission, and presentation of data at national and international meetings. The SMDCD will have both an inward and outward facing presence, including assisting the clinical operations team in the site evaluation and selection process for assigned clinical trials. This position may also work closely with preclinical functions and may be involved in interactions with strategic or collaboration partners.

Key responsibilities:

· Contributes to the overall clinical strategy for all or select RP programs from early development, through regulatory submissions and post-commercialization, with an emphasis from mid to late stages of development.

· Serve as Replimune’s clinical lead and point person on assigned programs and clinical trials from initiation to study discontinuation. Leads or facilitates cross-functional clinical development and/or study team(s) on the following activities, including but not limited to:

o Designs studies as per clinical strategy, driving clinical activities related to preparation and approval of synopses, protocols and the conduct of clinical studies.

o Responsible for the relevance and accuracy of medical science underpinning of clinical study based on thorough scientific review and consultation with internal and external experts.

o Organizes and conducts consultations with global opinion leaders and

contributing to or leading Advisory Board meetings.

o Reviews and finalizes the medical and scientific portions of clinical study concepts and clinical study protocols and amendments.

o Reviews and edits documents related to trials, such as monitoring plans, SAPs, amendments, IRB/IEC submissions and regulatory submissions.

o Responsible for oversight of cross-functional study team and provides medical guidance to the clinical study teams.

· Responsible for medical monitoring activities in partnership with CRO, pharmacovigilance, biostatistics, clinical operations, and program leadership for, including but not limited to,

o Assessing issues related to study conduct

o Individual subject safety, in partnership with CRO responsible for trial delivery. Program, trial or data risks, creating, and implementing mitigation strategies

o Maintains and develops relationship with key study investigators

· Provide medical input and guidance to development and study/project teams and work collaboratively with cross-functional team members, such Clinical Operation, Data Management, other Medical Directors and Clinical Scientists, Pharmacovigilance and Medical Affairs to deliver clinical trial data, to assure data integrity, to provide consolidated information for trial progress. Direct the interpretation of clinical and translational study data. Presents to internal governance committee or management and help determine how individual study results impact the overall compound strategy.

· Authors/contributes to clinical sections of communications/documentation for regulatory agencies and is a key contributor in meetings with agencies. Supports generation and coordination of clinical documents and deliverables in support of regulatory filings, such as clinical study reports, DSURs, PSURs, regulatory submission sections, and investigator’s brochures, as well as provides input to regulatory questions.

· Ensures that all the activities and clinical programs are in compliance with the GCP and regulatory requirements, as well as local and institutional requirements.

· Work with the Regulatory team and other cross functional representatives to ensure the timely preparation of high-quality documents to be submitted to the FDA and other health authorities for review, and represent Clinical at meetings with the FDA, EMEA and other regulatory agencies.

· Work with program management to assure deep integration of objectives, achievement of milestones according to the timelines, and optimal use of resources across functions.

· Support the tactical development of clinical trials programs, including the prioritization of investigator sponsored studies in the context of the overall clinical strategy, and literature reviews.

· Collaborate with Medical Affairs on the development of educational materials intended for all stakeholders, including healthcare providers and patients, that is medically accurate and appropriate.

· Maintain understanding of competitors and clinical developments in relevant therapeutic areas by attending scientific meetings and tracking literature.

· Ensure the consistent application of state-of-the-art scientific and ethical methods to design clinical investigational trials of the highest quality.

· Help assure that all activities within clinical development are executed compliantly and to global industry standards as well as within expected scope, budget and timelines.

· Collaborate with colleagues in research and preclinical development functions to move product candidates from entry into clinical investigations.

· Actively support business development to evaluate product candidates, determine product indications and assist in related strategic planning and partnering discussions.

Other responsibilities:

· Completes and maintains Compliance training; provides input on new initiatives and makes recommendations on new compliance procedures; assists in the development of compliance and quality training materials.

· Will work with commercial to develop a commercialization strategy which will include development of TPPs based on competitive assessment and target positioning and will align the clinical development strategy with the commercial strategy, and may include the design of post-marketing studies, as appropriate.

· May be asked to serve on Replimune internal committees, as appropriate.

· May be asked to serve as a Replimune representative on external committees and foundations, as appropriate.

· Assists with the recruitment of new employees, mentors junior team members, contributes to relevant training materials, as well as provides guidance and assistance in new hires’ professional development.

· Other duties as assigned.

Educational requirements:

· A medical degree (M.D.) required, additional science degree (PhD) desirable but not required.

· Training and experience in oncology and immunotherapy is required. Oncology board certification preferred but not required.

Experience and skill requirements:

· 7+ years of global clinical development experience and success within other biotech / pharmaceutical companies.

· Professional knowledge and skills working with solid tumor oncology therapeutic.

· Must possess a high level of understanding of the fundamentals of clinical development, such as experience with protocol development and follow up, including but not limited to: Study monitoring, data collection and analysis, database cleaning and database lock.

· Demonstrated experience in designing development strategies (including role of biomarkers) and leading Phase 1-3 programs coupled with the appropriate regulatory and commercial experiences of successful oncology drug product approval and launch.

· Proactive, creative, forward-thinker with the ability to think innovatively about integrated strategy for research, clinical and commercial activities, while accurately anticipating future consequences and trends.

· Knowledge of all the requirements and processes needed to take a drug candidate through clinical development to registration preferred.

· Experience in late-stage medical affairs and commercial environments, including the planning of and participation in pre-commercial activities for late stage to commercial products preferred.

· Demonstrated familiarity with biostatistics principles used in the analysis and interpretation of clinical trial data.

· Familiarity with and ability to interface effectively with appropriate Key Opinion Leaders (KOLs), investigators, CROs, and other entities.

· Excellent written and verbal scientific communication skills and analytical abilities.

· Knowledge of applicable International Compliance guidelines and regulations, FDA, EMA, PMDA regulations and expectations, Good Clinical Practice, ICH guidelines, and clinical drug development.

· Experience in representing the sponsor in front of regulatory agencies.

· Knowledge of the day-to-day medical monitoring of clinical trials (e.g., responding to questions about patient eligibility and protocol waivers; review of safety parameters; working closely with Pharmacovigilance on processing SAEs, including the composition of SAE narratives; and IND expedited safety reports).

· Prior experience with vendor selection and management is expected.

· Experience with the development and support of related SOPs and policies is expected.

· Experience with partnerships and strategic alliances is expected.

· Skilled in multiple computer-based tools, in addition to software programs such as Word, Project, PowerPoint, Excel, etc.

· Domestic and international travel (up to approximately 30%) is required

Salary Range

Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $318,000-$411,500. The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer.

At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown.

About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit .

We are an Equal Opportunity Employer.